Recent progress in cancer care continue to offer optimism for patients. Researchers are intensely exploring novel approaches, including harnessing the immune system, targeted agents, and individualized medicine . A major finding published this week demonstrates the efficacy of a new drug in combating advanced NSCLC. Furthermore, continued trials ar